🔴 Senti Biosciences is trading 5% down

Senti Biosciences is trading 5.06% lower at $0.31, with no confirmed company announcement explaining the move in available October 8 coverage.

• A shareholder meeting was scheduled for October 8 to consider the Celadon merger and a possible reverse split; available information does not establish either as the cause.
• The Nasdaq was down 0.55% in the supplied market context, which may be contributing to pressure, but Senti Biosciences’ decline was larger and no specific catalyst is confirmed.